First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT

Saved in:
Bibliographic Details
Main Authors: Annie Bjäreback, Olof Jonmarker, Antonios Tzortzakakis, Emma Jussing, Chunde Li, Renske Altena, Cecilia Hindorf, Anna Orlova, Rimma Axelsson, Thuy A. Tran
Format: Article
Language:English
Published: SpringerOpen 2025-02-01
Series:EJNMMI Research
Online Access:https://doi.org/10.1186/s13550-025-01204-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325825940258816
author Annie Bjäreback
Olof Jonmarker
Antonios Tzortzakakis
Emma Jussing
Chunde Li
Renske Altena
Cecilia Hindorf
Anna Orlova
Rimma Axelsson
Thuy A. Tran
author_facet Annie Bjäreback
Olof Jonmarker
Antonios Tzortzakakis
Emma Jussing
Chunde Li
Renske Altena
Cecilia Hindorf
Anna Orlova
Rimma Axelsson
Thuy A. Tran
author_sort Annie Bjäreback
collection DOAJ
format Article
id doaj-art-bc9f85f8453745de930255bac370a346
institution Kabale University
issn 2191-219X
language English
publishDate 2025-02-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj-art-bc9f85f8453745de930255bac370a3462025-08-20T03:48:18ZengSpringerOpenEJNMMI Research2191-219X2025-02-011511610.1186/s13550-025-01204-yFirst-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CTAnnie Bjäreback0Olof Jonmarker1Antonios Tzortzakakis2Emma Jussing3Chunde Li4Renske Altena5Cecilia Hindorf6Anna Orlova7Rimma Axelsson8Thuy A. Tran9Department of Nuclear Medicine and Medical Physics, Section Nuclear Medicine Huddinge, Karolinska University HospitalDivision of Radiology, Department for Clinical Science, Intervention and Technology (CLINTEC), Karolinska InstitutetDepartment of Nuclear Medicine and Medical Physics, Section Nuclear Medicine Huddinge, Karolinska University HospitalDepartment of Oncology-Pathology, Karolinska InstitutetDepartment of OncologyDepartment of Oncology-Pathology, Karolinska InstitutetDepartment of Molecular Medicine and Surgery, Karolinska InstitutetDepartment of Medicinal Chemistry, Uppsala UniversityDepartment of Molecular Medicine and Surgery, Karolinska InstitutetDepartment of Oncology-Pathology, Karolinska Institutethttps://doi.org/10.1186/s13550-025-01204-y
spellingShingle Annie Bjäreback
Olof Jonmarker
Antonios Tzortzakakis
Emma Jussing
Chunde Li
Renske Altena
Cecilia Hindorf
Anna Orlova
Rimma Axelsson
Thuy A. Tran
First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
EJNMMI Research
title First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
title_full First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
title_fullStr First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
title_full_unstemmed First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
title_short First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT
title_sort first in human experience with grpr antagonist 68ga ga nota peg2 rm26 in prostate and breast cancer patients using pet ct
url https://doi.org/10.1186/s13550-025-01204-y
work_keys_str_mv AT anniebjareback firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT olofjonmarker firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT antoniostzortzakakis firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT emmajussing firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT chundeli firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT renskealtena firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT ceciliahindorf firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT annaorlova firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT rimmaaxelsson firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct
AT thuyatran firstinhumanexperiencewithgrprantagonist68gaganotapeg2rm26inprostateandbreastcancerpatientsusingpetct